Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Children Ma Xing Jie Du Granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is specifically designed for the treatment of pediatric Mycoplasma pneumonia, particularly for cases characterized by the TCM syndrome of wind-heat obstructing the lung. The formulation is typically used as an adjunctive therapy in combination with standard antibiotics like azithromycin. The granules are intended to alleviate clinical symptoms such as cough, fever, and lung inflammation by clearing heat, detoxifying the body, and facilitating lung ventilation. As a TCM granule, it likely contains botanical extracts such as Ephedra (Ma Huang) and Apricot Kernel (Xing Ren), which are traditional components for treating respiratory distress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Children Ma Xing Jie Du Granules.